Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q156
SBA

SBA — Single Best Answer · Review

Question 156

Delivery suite → Haemorrhage

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 7727bafe-6a09-488c-b5fb-c6319fde3b5f

Classification

Speciality
Obstetrics and Gynaecology
Group
Clinical
Title
Delivery suite
Topic
Haemorrhage
Subtopic 1
Antepartum haemorrhage
Subtopic 2
General
Subtopic 3
Management
Question Type
SBA

Question

SSBA
Question Header
A woman at 29+4 weeks presents with APH and regular painful contractions. Placenta praevia has been excluded. She has received the first dose of antenatal corticosteroids. Initially her observations and CTG were reassuring, and selective tocolysis was being considered. Thirty minutes later the bleeding increases, her pulse rises to 122 beats/min and the CTG develops recurrent late decelerations. What is the most appropriate modification of the management plan?
Question Stem
—

Options

A Continue tocolysis until the corticosteroid course is complete because gestation is below 30 weeks
B Increase the tocolytic dose because fetal compromise is likely to reflect prematurity
C Stop considering pregnancy prolongation and proceed towards delivery while resuscitation continues
D Continue tocolysis provided ultrasound shows no retroplacental clot
E Delay the decision until haemoglobin demonstrates a significant fall

Explanation

Any potential benefit from prolonging a preterm pregnancy is subordinate to maternal and fetal safety. Tocolysis may be considered only selectively in APH when there is no maternal or fetal indication for delivery and under senior obstetric supervision. Increasing haemorrhage, maternal tachycardia and new pathological fetal heart rate changes fundamentally alter the risk-benefit balance. Delivery should no longer be delayed simply to complete corticosteroids. A negative ultrasound or initially preserved haemoglobin cannot override clinical deterioration.

Option Validity

A) Completion of an antenatal corticosteroid course must not delay indicated delivery when maternal or fetal compromise develops.

B) Pathological fetal heart rate changes during worsening antepartum haemorrhage cannot safely be attributed to prematurity and managed by increasing tocolysis.

D) Ultrasound cannot reliably exclude placental abruption and should not be used to justify delaying necessary delivery.

E) Severe acute blood loss may initially occur without a substantial reduction in haemoglobin concentration; clinical deterioration should determine management.

Further Reading

RCOG Green-top Guideline No. 63. Antepartum Haemorrhage. Royal College of Obstetricians and Gynaecologists; 2011.

Source & metrics

Authored Difficulty
4.00
Evaluation Score
—
Destination
Site
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question